Related Experiment Video
Updated: Sep 24, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
H2FPEF Score and Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous
Nail Burak Ozbeyaz1, Gokhan Gokalp1, Engin Algul2
1Pursaklar State Hospital, 37511Department of Cardiology Clinic, Ankara, Turkey.
Insights
The H2FPEF score can predict contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Higher scores indicate increased risk, aiding early intervention for this common complication.
Area of Science:
- Cardiology
- Nephrology
- Medical Diagnostics
Background:
- Contrast-induced nephropathy (CIN) is a frequent complication following coronary angiography and percutaneous coronary intervention (PCI).
- Predictive tools for CIN are crucial for patient management and risk stratification.
- The H2FPEF score, initially developed for heart failure with preserved ejection fraction, has potential for other cardiovascular risk assessments.
Purpose of the Study:
- To investigate the association between the H2FPEF score and the development of CIN in patients undergoing PCI for acute coronary syndrome (ACS).
- To determine if the H2FPEF score is an independent predictor of CIN.
- To establish a predictive cutoff value for the H2FPEF score for CIN development.
Main Methods:
- Retrospective analysis of 1346 patients who underwent PCI for ACS between December 2018 and January 2021.
- Calculation of H2FPEF scores for all included patients.
- Statistical analysis including correlation and receiver operating characteristic (ROC) curve analysis to assess the predictive value of the H2FPEF score for CIN.
Main Results:
- Patients who developed CIN had significantly higher H2FPEF scores compared to those who did not (4.10 ± 1.92 vs 2.28 ± 1.56, P < .001).
- The H2FPEF score was identified as an independent risk factor for CIN (OR 1.633, P < .001), alongside age, diabetes, pulmonary hypertension, and infarct artery location.
- A strong positive correlation was observed between CIN and H2FPEF score (rpb = .376, P < .001).
- The optimal H2FPEF score cutoff for predicting CIN was 2.5, with 79.8% sensitivity and 64.1% specificity.
Conclusions:
- The H2FPEF score demonstrates significant potential as a predictive tool for contrast-induced nephropathy in ACS patients undergoing PCI.
- Utilizing the H2FPEF score can aid clinicians in identifying high-risk individuals, potentially enabling preventative strategies.
- Further prospective studies are warranted to validate these findings and integrate the H2FPEF score into clinical practice for CIN prevention.
Abstract:
Contrast-induced nephropathy (CIN) is one of the most common complications associated with coronary angiography and percutaneous coronary intervention (PCI). This study evaluated the relationship between the H2FPEF (obesity (H), hypertension(H), atrial fibrillation (F), pulmonary hypertension (P), an age >60 years (E), and E/e' > 9 (F)) score which is used to diagnose heart failure with preserved ejection fraction and CIN. Patients (n = 1346) who underwent PCI for acute coronary syndrome (ACS) between December 2018 and January 2021 were retrospectively included. Contrast-induced nephropathy patients had significantly higher H2FPEF scores (4.10 ± 1.92 vs 2.28 ± 1.56, P < .001). In addition, the H2FPEF score was found to be an independent risk factor for the development of CIN (Odd Ratio 1.633 95% CI (1.473-1.811), P < .001) together with age, diabetes mellitus, systolic pulmonary arterial pressure, and left anterior descending as an infarct-related artery. According to point biserial correlation analysis, CIN and H2FPEF score have a strong correlation (rpb = .376, P < .001). The receiver operating characteristic curve showed the optimal cutoff value of the H2FPEF score to predict the development of CIN was 2.5, with 79.8% sensitivity and 64.1% specificity. In conclusion, the H2FPEF score may predict the development of CIN in patients presenting with ACS and undergoing PCI.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Imaging Studies VII: Vascular Imaging

